FIELD: medicine.
SUBSTANCE: invention represents an airra-DLL4-antibody, a coding polynucleotide, a vector, a host cell, a method for producing an antibody, compositions containing such antibodies, and methods of application thereof.
EFFECT: invention can be used effectively for treatment or prevention of pathological conditions associated with DLL4 expression or activity.
27 cl, 59 dwg, 3 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NRR Notch1 ANTIBODIES AND METHODS OF APPLICATION THEREOF | 2008 |
|
RU2476443C2 |
| ANTIBODIES AGAINST NOTCH2 AND METHODS FOR APPLICATION THEREOF | 2009 |
|
RU2580029C2 |
| ANTIBODIES TO JAGGED AND METHODS OF THEIR USE | 2013 |
|
RU2666990C2 |
| ANTI-EphB4 ANTIBODIES AND METHODS OF USING SAID ANTIBODIES | 2007 |
|
RU2450020C2 |
| EPHRINE B2 ANTIBODIES AND METHODS FOR USING THEM | 2007 |
|
RU2451031C2 |
| THERAPEUTIC DLL4-BINDING PROTEINS | 2010 |
|
RU2570639C2 |
| ANTI-TAT226 ANTIBODIES AND IMMUNOCONJUGATES | 2007 |
|
RU2448980C2 |
| ANTIBODIES AGAINST FGFR3 AND METHODS OF THEIR APPLICATION | 2010 |
|
RU2568066C2 |
| ANTIBODIES AGAINST AXL AND THEIR APPLICATION | 2011 |
|
RU2577986C2 |
| ANTI-LRP6 ANTIBODIES | 2011 |
|
RU2587625C2 |
